feed,title,long_url,short_url
Benzinga,Why Did Aeglea BioTherapeutics Shares Nosedived To 52-Week Low On Monday Premarket?,https://benzinga.com/general/biotech/21/12/24456473/why-did-aeglea-biotherapeutics-shares-nosedived-to-52-week-low-on-monday-premarket,https://j.mp/3y2vOKq
Benzinga,Bolt Biotherapeutics Reveals Early Data From BDC-1001 Immuno-Oncology Candidate,https://benzinga.com/general/biotech/21/12/24456308/bolt-biotherapeutics-reveals-early-data-from-bdc-1001-immuno-oncology-candidate,https://j.mp/3rFyqfS
